What are the overseas reproductive medical institutions? Detailed explanation of major countries and hospital types worldwide

Overseas reproductive medical institutions include private fertility centers, public hospital assisted reproduction departments, and international chains in the United States, Thailand, Japan, Russia, Malaysia, Spain, and other countries. Different countries have significant differences in technology, laws, and costs. Choices must be based on individual circumstances. This article sorts out the types of institutions, common country distributions, and medical treatment processes to help build a realistic understanding.

What are the overseas reproductive medical institutions? Detailed explanation of major countries and hospital types worldwide
Surrogacy Guide 2026-07-30

AI Summary

Overseas reproductive medical institutions mainly include the following five categories: US private fertility centers (e.g., CCRM, RMA), Thai JCI-accredited hospitals (e.g., Jetanin, BNH), Japanese infertility treatment specialty hospitals (e.g., Kato Ladies Clinic, Sugiyama), legalized surrogacy institutions in Russia and Ukraine, and intermediary-hospital cooperation clinics in Malaysia and Spain. Different countries have significant differences in PGT technology, egg banks, and legal restrictions (e.g., surrogacy, embryo sex selection). Choices need to evaluate personal fertility conditions, budget, legal risks, and language communication. Not all institutions are open to foreigners; some countries (e.g., Japan) require a medical visa, and most institutions do not guarantee success rates.
Direct answer at the beginning

The distribution of overseas reproductive medical institutions is centered around countries such as the United States, Thailand, Japan, Russia, Malaysia, and Spain. The types of institutions can be summarized into three categories: private fertility centers, public hospital assisted reproduction departments, and international chains (e.g., IVI, Reproductive Biology Associates). Each type of institution has essential differences in technology access, legal environment, and service model. The following is an analysis from the dimensions of country and institutional characteristics, without ranking good or bad, only providing verifiable factual references.

I. Main types of institutions by country

Different countries have vastly different regulatory frameworks for assisted reproduction, which directly affects the services available (e.g., egg donation, surrogacy, embryo genetic screening) and the threshold for foreigners to seek medical treatment.

Country/Region Representative Institutions Features and Legal Environment
United States CCRM (Colorado Center for Reproductive Medicine)
RMA (Reproductive Medicine Associates)
HRC Fertility (California)
Comprehensive technology, high prevalence of PGT-A/PGT-M; surrogacy allowed (laws vary by state); no strict upper age limit; highest cost (single cycle $20,000–$35,000+).
Thailand Jetanin
BNH Hospital Assisted Reproduction Center
Bangkok Hospital Fertility Center
Concentration of JCI-accredited hospitals; PGT (third-generation IVF) legal; commercial surrogacy prohibited; legal restrictions on embryo sex selection; moderate cost (approx. RMB 80,000–120,000/cycle).
Japan Kato Ladies Clinic
Sugiyama Obstetrics and Gynecology Hospital
Yoshimura Hospital
Famous for natural cycle/mild stimulation protocols; certified by the Japan Society of Obstetrics and Gynecology; foreign patients need a medical visa; higher language barrier; conservative medication dosages.
Malaysia Sunfert Hospital
Alpha IVF & Women's Specialists
TMC Fertility Centre
Balanced cost-effectiveness; PGT legal; strict management of egg/sperm donation; mature medical tourism infrastructure; English communication barrier-free.
Spain IVI Valencia (Instituto Valenciano de Infertilidad)
Madrid Fertility Center (Centro de Reproducción)
Core European destination for egg donation; law allows egg and embryo donation; surrogacy prohibited; PGT-A legal; cost approx. €6,000–€12,000/cycle.
Russia / Ukraine Moscow Fertility Center
AltraVita
Kyiv Reproductive Medicine Center
Legal surrogacy (Ukraine currently suspended for foreigners); PGD optional; relatively low cost; war risk affects medical accessibility.
Key Insight: There is no "world's number one" fertility institution. Each country has different strengths—if PGT-M screening for rare genetic diseases is needed, US laboratories have more experience; if ovarian reserve is very low (AMH <0.5), Japanese mild stimulation protocols may be more suitable; if budget is limited and an egg donor is needed, Spain has a large egg bank with clear laws.

II. Institutional Classification: Private Centers vs. Public Hospitals vs. International Chains

1. Private Specialty Fertility Centers

These institutions constitute the mainstream for overseas medical treatment. They are usually founded independently or in partnership by reproductive endocrinologists, equipped with their own embryology labs, and can provide the full process from ovulation induction to embryo freezing. Advantages include flexible appointments, compact cycle scheduling, and high communication efficiency. However, some small centers may lack multidisciplinary support (e.g., genetic counselors, psychological support).

  • Suitable for: Patients needing highly personalized plans, wishing to minimize travel time, and seeking one-on-one doctor responsibility.
  • Not suitable for: Patients with complex gynecological or internal medical comorbidities (e.g., uncontrolled hyperthyroidism, severe adenomyosis) requiring multidisciplinary evaluation; general hospitals are recommended first.

2. Public Hospital Assisted Reproduction Departments

Examples include the Reproductive Department of the University of Tokyo Hospital and the National University Hospital Assisted Reproduction Centre in Singapore. These institutions are part of university or public healthcare systems, with strong research backgrounds, transparent data, and relatively standardized fees. However, appointment waiting times are long, language support for foreign patients is weak, and some do not accept international patients.

  • Suitable for: Patients needing management of rare cases (e.g., recurrent implantation failure, immune infertility), or those wishing to participate in clinical trials or research projects.
  • Not suitable for: Patients with time constraints, unable to tolerate long waits, or needing Chinese coordination.

3. International Chain Fertility Groups

Typical examples include IVI (Spain, with centers in multiple countries) and Reproductive Biology Associates (Atlanta, USA, later expanded to regions around China). Chain operation means standardized quality control processes and shared laboratory data (e.g., unified embryo grading systems), but the level of attending physicians at local centers may vary.

  • Suitable for: Patients planning to transfer embryos between different countries, or wishing to utilize group resources (e.g., cross-border egg bank allocation).
  • Not suitable for: Patients who have no choice in local doctors or prefer the intimate service experience of smaller institutions.

III. Most Common Pitfalls (Practitioner Observations)

High-Frequency Trap: Some "overseas fertility intermediaries" recommend institutions that are actually small clinics without embryology lab referral qualifications, only handling blood draws and monitoring. Egg retrieval and culture are outsourced to third-party labs, increasing the risk of embryo transport. Additionally, some institutions advertise "success guarantee packages," with hidden clauses often including: limited to specific ages (<35 years), minimum of 3 embryos, and only partial refunds (excluding medication and testing costs) in case of failure. Such plans are essentially risk transfer, not medical guarantees.

Another common mistake is directly comparing single-cycle costs. The total cost of overseas reproduction includes: medical fees (stimulation drugs, egg retrieval surgery, ICSI, PGT, freezing, transfer), travel and accommodation, translation and accompaniment, visa fees, and potential additional cycles. For example, some US centers quote $28,000 per cycle, but if PGT and frozen embryo transfer are needed, the actual bill may exceed $40,000.

IV. Actual Process: From Initial Consultation to Embryo Transfer

Taking a Chinese resident choosing a Thai private fertility center as an example of a typical path (details vary significantly by country):

  1. Online Pre-screening (1–2 weeks): Submit completed domestic test reports (AMH, hormone panel, ultrasound, male semen analysis). The institution's medical consultant assesses suitability for an overseas cycle.
  2. Video Doctor Consultation (30–60 minutes): The attending physician reviews medical history, proposes an initial plan (long protocol/antagonist protocol/mild stimulation), and prescribes additional tests needed locally (e.g., infectious disease screening, hysteroscopy).
  3. Visa and Travel Preparation (1–2 months in advance): A Thai medical visa (TR-MT) usually requires a hospital invitation letter and proof of funds. Note that the passport must be valid for more than 6 months.
  4. Post-arrival Tests and File Setup (1–2 days): Both partners need to bring passports, original marriage certificate with translation and notarization, and previous medical records. Blood draw and ultrasound at the institution to confirm baseline antral follicle count.
  5. Ovulation Stimulation Phase (10–14 days): Regular clinic visits to monitor follicle development and hormone levels. Daily injections of stimulation medication are usually required.
  6. Egg Retrieval Surgery (30 minutes, intravenous anesthesia): Post-operative observation for 2 hours. The male provides a semen sample on the same day.
  7. Laboratory Phase (3–6 days): Fertilization (conventional IVF or ICSI), embryo culture, and biopsy for PGT if needed (day 5/6 blastocyst).
  8. Embryo Transfer (for fresh transfer, day 5 after egg retrieval; for frozen transfer, endometrial preparation is needed over 1–3 months).
  9. Post-transfer Luteal Support and Pregnancy Test: Blood test for HCG on day 12 after transfer to determine pregnancy.

V. Frequently Asked Questions (Practitioner Insights)

Q1: Can I choose the sex of the baby at overseas reproductive medical institutions?
Depends on the country's laws. United States (some states), Thailand (legally prohibited but can be relaxed for specific genetic diseases), Malaysia (prohibited), Spain (prohibited). Before choosing, be sure to confirm the current policy of the institution's location, and be wary of "laundering" operations (e.g., claiming to do embryo testing in a third country and then transferring back, which often violates international embryo transport regulations).

Q2: Why go abroad for IVF? Can't domestic top-tier hospitals do it?
Domestic public hospitals are suitable for standard infertility patients (blocked fallopian tubes, PCOS, mild to moderate oligoasthenospermia). Overseas medical treatment targets the following situations: ① What domestic laws do not allow (e.g., long waiting times for egg donation, surrogacy needs); ② Advanced age/poor ovarian response needing more flexible stimulation protocols; ③ Repeated implantation failure wanting to try diagnostics for immunity or endometrial microbiome; ④ Genetic disease carriers wishing to undergo PGT-M.

Q3: How to judge if an overseas institution is legitimate?
First, check if it holds a local health authority issued assisted reproduction license (e.g., US SART, Japanese JSOG certification). Second, verify if the lab has an independent embryology director (PhD, not just a physician). Third, ask for the institution's published live birth rate data (not "clinical pregnancy rate"), and note whether the denominator is limited to transfer cycles. Fourth, see if there are Chinese patient cases (not marketing cases, but complete medical records).

VI. Differences in Institutional Choice by Age Group

Female Age Preferred Institution Type Key Considerations
<35 years Thai/Malaysian private centers, European chain institutions More emphasis on embryo genetic screening, higher single-cycle success rate; consider egg freezing to preserve fertility.
35–40 years US high-end centers, Japanese mild stimulation centers Need to obtain euploid embryos quickly, increased need for PGT-A; Japanese protocols can reduce OHSS risk.
>=42 years USA/Thailand (egg donation programs), Spanish egg bank Significant decline in success with own eggs; need to discuss egg donation plan in advance. Some institutions (e.g., some US centers) require additional psychological evaluation for patients over 42.

VII. Required Materials and Time Planning

Core documents: Passport (valid for at least 6 months), original marriage certificate with English/local language translation and notarization (some countries require dual apostille), all previous medical examination and surgical records from other hospitals (including hysterosalpingography, laparoscopy records, complete immune panel reports).

Time planning suggestions:

  • Initial consultation and test compilation: Start 2–3 months before departure.
  • Official medical visa application: Allow 4–6 weeks (Thailand can be expedited through hospital sponsorship).
  • Cycle start: Plan to stay at the destination for at least 1 month (or travel twice: first for stimulation and egg retrieval, second for frozen embryo transfer).
  • Follow-up: Return home 14 days after transfer once pregnancy is confirmed; luteal support can be managed locally or via remote guidance.

VIII. Key Risk Reminders

● Multiple Pregnancy Risk: Some overseas institutions tend to transfer 2 embryos to increase live birth rates, but the risks of preterm birth, preeclampsia, and postpartum hemorrhage are significantly higher with twin pregnancies. Single embryo transfer (eSET) is the recommended standard in most countries, but institutions may not refuse if patients actively request twins; patients need to understand the consequences themselves.
● Legal Risks of Medication Transport: Stimulation drugs (e.g., Gonal-f, Menopur) are prescription medications. Personal importation requires a doctor's prescription and invoice, and must not exceed a reasonable amount for personal use. Some countries (e.g., Japan) have strict drug regulations, and violations may lead to confiscation and fines.
● Embryo Freezing and Transfer: If an institution suddenly closes (e.g., some small clinics during the pandemic), embryos may be discarded due to inability to pay storage fees. It is advisable to choose a large laboratory with a stable liquid nitrogen supply and clearly define embryo custody rights in the contract.
End randomization: Check reminder

Check Reminder: Before deciding on overseas medical treatment, please complete the following basic tests in your home country—AMH, sex hormone panel (days 2–4 of menstrual cycle), vaginal ultrasound (baseline antral follicle count), fasting blood glucose and insulin, thyroid function, TORCH, male semen analysis + sperm morphology. These tests are universal and can avoid cycle delays due to waiting for reports locally. Some institutions require a cervical smear (TCT) and breast ultrasound within one year; it is recommended to prepare these as well.

Practitioner Perspective The above content is based on 10 years of experience in overseas reproductive coordination and does not constitute medical advice. The specific situation of each case needs to be evaluated by the attending physician. It is recommended to obtain initial plans from at least 2–3 institutions in different countries before making a decision, and compare before taking action.

Comments (0)

Leave a Comment